Via a Google+ post, Alphabet President Sergey Brin said Andy Conrad would act as Life Sciences CEO. Day to day, nothing will change:
While the reporting structure will be different, their goal remains the same. They’ll continue to work with other life sciences companies to move new technologies from early stage R&D to clinical testing—and, hopefully—transform the way we detect, prevent, and manage disease.
While at Google X, the team now working for Alphabet invented a glucose monitoring contact lens meant to help diabetics monitor blood sugar levels.
➤ Sergey Brin [Google+]